濮阳东方妇科医院做人流手术收费多少-【濮阳东方医院】,濮阳东方医院,濮阳东方治病专业,濮阳东方医院男科看早泄好不,濮阳东方医院男科地址在哪,濮阳东方妇科咨询专家热线,濮阳东方看男科口碑好价格低,濮阳东方看妇科病价格透明

BEIJING, Aug. 22 (Xinhuanet) -- Researchers have discovered how a human egg captures an incoming sperm for fertilization, paving the way to help couples suffering from infertility, according to media reports on Monday.An international team of researchers found that a sugar chain known as the sialyl-lewis-x sequence (SLeX) makes the outer coat of the egg “sticky,” which has proven to be helpful in binding the egg and the sperm.As a result, this observation has filled in a huge gap in the understanding of fertility and provides hope for ultimately helping couples who currently cannot conceive.Scientists and doctors know that a sperm identifies an egg when proteins on the head of the sperm match and bind to a series of specific sugars in the egg’s outer coating. With a successful match of proteins, the outside surfaces of the sperm and egg then bind together before merging, which is then followed by delivery of sperm’s DNA into egg.To identify this molecules, the researchers used ultra-sensitive mass-spectrometric imaging technology to observe and identify which molecules are most likely to be key in the binding process.They experimented with a range of synthesised sugars in the laboratory and found that it is SLeX that specifically binds sperm to an egg.According to the World Health Organisation, infertility affects about 15 percent of reproductive-aged couples around the world and almost one in every seven couples in Britain has problems conceiving a child for various reasons.
SAN FRANCISCO, June 8 (Xinhua) -- Facebook Inc. will be probed by European Union (EU) regulators over its latest facial recognition feature rolling out worldwide, U.S. media reported on Wednesday.The feature, called Tag Suggestions, uses face recognition software to match users' new photos to other photos they are tagged in. It groups similar photos together and suggests the name of the friend in the photos.Facebook rolled out the feature in the United States late last year, where users can opt out of the feature by going to their private settings. But Facebook switched it on by default without telling users first when it became available on Tuesday in countries outside of the United States.A group of privacy watchdogs from 27 EU nations will study the measure for possible rule violations, a Luxembourg official of Article 29 Data Protection Working Party told Bloomberg. The Working Party, an independent EU advisory body on data protection and privacy, comprises the data protection regulators of all the 27 EU member states."Tags of people on pictures should only happen based on people' s prior consent and it can't be activated by default," said the Luxembourg official, Gerald Lommel. He noted that such automatic features "can bear a lot of risks for users" and the European data- protection regulators will "clarify to Facebook that this can't happen like this."Authorities in Britain and Ireland said they are also looking into the new function on Facebook. The British Information Commissioner's Office told Bloomberg that "the privacy issues that this new software might raise are obvious," saying it is "speaking to Facebook" about the issue.Facebook has been under scrutiny by EU regulators for several privacy concerns, such as users' default settings and how the company uses the information collected from its social network website.

BEIJING, Aug. 18 (Xinhua) -- A controlled trial has found that Chinese herbal medicine decoction maxingshigan-yinqiaosan has a similar efficacy to oseltamivir in reducing time to fever resolution in people suffering mild H1N1 influenza virus infections.Carried out by a group of Chinese researchers, headed by Prof. Wang Chen with Beijing Chao-Yang Hospital under the Capital Medical University, the study was published by the famous internal medicine journal Ann Intern Med on Tuesday.Participants of the trial were 410 young adults aged 15 to 59 years with laboratory-confirmed H1N1 influenza.The researchers concluded that both active intervention, alone and in combination, were effective in reducing time to fever resolution in young adults with H1N1 flu, and therefore suggest that maxingshigan-yinqiaosan may be an alternative to oseltamivir.
WASHINGTON, June 7 (Xinhua) -- Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study published Tuesday in Gastroenterology, the official journal of the American Gastroenterological Association Institute.The study shows that patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non- drinkers.Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable serum at week 48; and 11 percent had a sustained virologic response. In contrast, the corresponding proportions for those who drank three or more cups of coffee per day were 73 percent, 52 percent, 49 percent and 26 percent, respectively."Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies."Approximately 70 to 80 percent of individuals exposed to HCV become chronically infected. Worldwide, these individuals are estimated to number between 130 and 170 million. Higher coffee consumption has been associated with slower progression of pre- existing liver disease and lower risk of liver cancer. However, the relationship with response to anti-HCV treatment had not been previously evaluated.
BEIJING, Aug. 22 (Xinhuanet) -- U.S. presidential candidate Rick Perry's controversial stem-cell treatment may inspire desperate patients to follow his lead while causing medical and legal concerns, according to media reports Monday.The Texas governor underwent a procedure on July 1 where stem cells, made from fat taken from his body, were put into his bloodstream to see if they might find their way to fix a bad back.The treatment carries potential risks ranging from blood clots to infection to cancer and may even run afoul of federal rules, doctors say. File photo of U.S. Republican presidential candidate Texas Governor Rick Perry."As a highly influential person of power, Perry’s actions have the unfortunate potential to push desperate patients into the clinic of quacks,” Harvard’s stem cell expert George Daley told the Associated Press.Worries about the safety and wisdom of this treatment are widespread among stem cell researchers as such a treatment has not been thoroughly vetted by researchers or approved by the FDA.
来源:资阳报